Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more
Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more
Health Technology Assessment… Value, Affordability, and… Establishing the Economic Value of Carbon-Minimal Inhalers Read more
Drug Development/R&D Economics of Innovation Competition The Importance of Diversity of Supply in Rare Diseases Markets Read more © VK Studio at stock.adobe.com
Health Technology Assessment… Measuring and Valuing Outcomes Societal preferences Understanding societal preferences for priority by disease severity in England & Wales Read more
Back Health Policy and Regulation Martina Garau < 1 min read|01/02/2007 Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group Read more Martina Garau Share: Twitter LinkedIn Facebook has-icon Email Copy URL Download publication Download Full Publication Health Policy and Regulation Martina Garau Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group Related Publications Health Technology Assessment… Value, Affordability, and… How Have HTA Agencies Evolved Their Methods Over Time? Read more Prevention Policy, Organisation and… Cancer The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target? Read more Biosimilars Economics of Innovation Generics The Dynamics of Drug Shortages Read more Health Technology Assessment… Economics of Innovation Innovation Innovation for Health System Efficiency and Improvement Read more
Health Technology Assessment… Value, Affordability, and… How Have HTA Agencies Evolved Their Methods Over Time? Read more
Prevention Policy, Organisation and… Cancer The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target? Read more
Health Technology Assessment… Economics of Innovation Innovation Innovation for Health System Efficiency and Improvement Read more